Pluristem Therapeutics Inc.

Haifa Street 350840, Tira, Israel

Website

972-74-710-8600

Pluristem Therapeutics Inc. (Nasdaq:PSTI) is a clinical-stage biotherapy company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for conditions such as inflammation, ischemia, muscle injuries, hematological disorders and exposure to radiation.

OUR VISION
Our vision is to leverage our advanced technology and our position as a global leader in cell therapy to develop, manufacture and market highly effective cell products that will heal patients around the world.

OUR STRATEGY
Our strategy is to develop powerful cell therapies that can be successfully commercialized to reach patients who need innovative treatment options. We develop placenta-derived, “off-the-shelf” products that do not require genetic or tissue matching prior to administration and could be delivered in almost any clinical setting. We design distinct cell products to target a variety of indications, and anticipate that a pipeline of differentiated products and indications will allow us to target large global markets. We explore new partnerships to advance our clinical development programs, while maintaining our strong commitment to current corporate, academic and government collaborations.

https://www.linkedin.com/company/pluristem-therapeutics/

https://www.youtube.com/channel/UC65WAbsbyKFNqvWWkfWZkKQ

Posted in Corporations

Reviews are disabled, but trackbacks and pingbacks are open.

Related Listings

Cellular Biomedicine Group

408 973 7884

1345 Avenue of the Americas, New York, NY 10105, USA

Cellular Biomedicine Group (Nasdaq:CBMG)brings together the world’s latest technology with industry-leading scientists and professors to research and develop safe treatments for those with serious conditions and diseases.… Read more…

Athersys

(216) 431-9900

3201 Carnegie Ave, Cleveland, OH 44115, United States

We are an international biopharmaceutical company engaged in the discovery and development of therapies designed to extend and enhance the quality of human life. Read more…

Vericel

(617) 588-5555

64 Sidney Street, Cambridge, MA 02139, USA

Vericel (Nasdaq:VCEL)  develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions. Read more…